Literature DB >> 15877777

Cost of anxiety disorders in Europe.

P Andlin-Sobocki1, H-U Wittchen.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15877777     DOI： 10.1111/j.1468-1331.2005.01196.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  33 in total

1.  Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms.

Authors:  Sebastian Trautmann; Jan Richter; Markus Muehlhan; Michael Höfler; Hans-Ulrich Wittchen; Katharina Domschke; Andreas Ströhle; Alfons O Hamm; Heike Weber; Tilo Kircher; Volker Arolt; Alexander L Gerlach; Georg W Alpers; Thomas Fydrich; Thomas Lang; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-15       Impact factor: 5.270

Review 2.  The burden of mental disorders.

Authors:  William W Eaton; Silvia S Martins; Gerald Nestadt; O Joseph Bienvenu; Diana Clarke; Pierre Alexandre
Journal:  Epidemiol Rev       Date:  2008-09-19       Impact factor: 6.222

3.  Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients.

Authors:  C Sabariego; M Brach; P Herschbach; P Berg; G Stucki
Journal:  Eur J Health Econ       Date:  2010-08-06

4.  Collaborative stepped care for anxiety disorders in primary care: aims and design of a randomized controlled trial.

Authors:  Anna D T Muntingh; Christina M van der Feltz-Cornelis; Harm W J van Marwijk; Philip Spinhoven; Willem J J Assendelft; Margot W M de Waal; Leona Hakkaart-van Roijen; Herman J Adèr; Anton J L M van Balkom
Journal:  BMC Health Serv Res       Date:  2009-09-08       Impact factor: 2.655

Review 5.  Global prevalence of anxiety and PTSD in immigrants: a systematic review and meta-analysis.

Authors:  Sohrab Amiri
Journal:  Neuropsychiatr       Date:  2022-02-11

6.  Gray and white matter volume abnormalities in generalized anxiety disorder by categorical and dimensional characterization.

Authors:  Kevin Hilbert; Daniel S Pine; Markus Muehlhan; Ulrike Lueken; Susann Steudte-Schmiedgen; Katja Beesdo-Baum
Journal:  Psychiatry Res       Date:  2015-10-13       Impact factor: 3.222

7.  Gender-specific associations between leisure-time physical activity and symptoms of anxiety: the HUNT study.

Authors:  Audun Brunes; Sigridur Lara Gudmundsdottir; Liv Berit Augestad
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-27       Impact factor: 4.328

8.  Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain.

Authors:  Marina De Salas-Cansado; Enrique Álvarez; José M Olivares; Jose L Carrasco; M Belén Ferro; Javier Rejas
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-10-21       Impact factor: 4.328

9.  Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain.

Authors:  Marina De Salas-Cansado; José M Olivares; Enrique Alvarez; Jose L Carrasco; Andoni Barrueta; Javier Rejas
Journal:  Clinicoecon Outcomes Res       Date:  2012-06-13

Review 10.  Exposure-in-vivo containing interventions to improve work functioning of workers with anxiety disorder: a systematic review.

Authors:  Erik Noordik; Jac J L van der Klink; Elmer F Klingen; Karen Nieuwenhuijsen; Frank J H van Dijk
Journal:  BMC Public Health       Date:  2010-10-11       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.